Tim Yarbrough
Analyst · UBS. Kunal, your line is live.
Thanks, Jason. This is Tim. I'll take these. So as far as OpEx seasonality, one thing I'll say off the bat is that it's been a while since we've seen more typical seasonality. So we have to go back to the 2019 and before that to kind of understand that picture. But in broad strokes, the hiring market really comes back to life after a holiday lull in January and then a fairly steady ramp into Q2 and then relatively flat through the balance of Q3, picking up into September, October and then back down during the holidays. And oftentimes, the very flexible operating expenses that we have, specifically in our go-to-market motion and sales and marketing, that will kind of follow a very similar pattern. And that's just basically because we're very responsive to the demand environment that we find ourselves. But like I said, at the top of the question, we haven't seen that typical seasonality for quite a while. And so, no operating expenses have bumped around a little bit, and that is because we are doing the very thing. So we're responding to the demand environment that we see. To your second question, R&D expense is coming down a little bit. We did a reduction in force back in Q2. And so what you're seeing in Q3 is the full impact of that rolling through the P&L. And so you see something similar as well in G&A, although to a lesser extent, to some other interest – other expenses increasing a tiny bit. And then sales and marketing came down primarily again because of our marketing efforts to invest where we see opportunities. And then to your last question, about our capital allocation strategy in general, our philosophy hasn't changed during all parts of the cycle. So when we look at organic investments, that is, by far and away, our first priority, and we still feel very good. We're cash flow positive. So clearly, we're well funded there. Secondly, we are scouring the world for interesting acquisition targets. So we're staying diligent there. And then to your point, on capital returns, we've been actively repurchasing shares over the years. And so we – the philosophy there is the same when we see a dislocation in the stock price. We're happy to invest in our own shares, and we approach that with the same mindset as we do with organic investments, i.e. with a longer-term mindset spanning years. So I'll just say we're still participating in share repurchases, but we do it opportunistically with priority being on organic investments and inorganic investments.